Cargando…

Eculizumab for the Treatment of Severe Antibody-Mediated Rejection: A Case Report and Review of the Literature

In renal transplantation, treatment options for antibody-mediated rejection are limited. Here, we report a case of severe AMR treated with eculizumab. A 50-year-old woman known for end stage kidney disease secondary to IgA nephropathy received a kidney transplant from a 50-year-old deceased donor. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Duy, Boucher, Anne, Collette, Suzon, Payette, Alexis, Royal, Virginie, Senécal, Lynne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958444/ https://www.ncbi.nlm.nih.gov/pubmed/27478676 http://dx.doi.org/10.1155/2016/9874261

Ejemplares similares

Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation
por: Mawad, Habib, et al.
Publicado: (2017)

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
por: Lanfranco, Luca, et al.
Publicado: (2017)

BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches
por: Lamarche, Caroline, et al.
Publicado: (2016)

The use of eculizumab as a bridge to retransplantation for chronic antibody-mediated rejection in a heart transplant recipient: a case report
por: Kearney, Katherine, et al.
Publicado: (2021)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Predicting Long-term Outcomes in Deceased Donor Kidney Transplant Recipients Using Three Short-term Graft Characteristics
por: Sandal, Shaifali, et al.
Publicado: (2023)

Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial
por: Marks, William H., et al.
Publicado: (2019)

Practice Patterns in the Treatment and Monitoring of Acute T Cell–Mediated Kidney Graft Rejection in Canada
por: Leblanc, Julie, et al.
Publicado: (2018)

Eculizumab in recalcitrant antiphospholipid antibody syndrome
por: Zapantis, Ekaterini, et al.
Publicado: (2014)

Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation
por: Yerly, Patrick, et al.
Publicado: (2022)

Hypothermic Perfusion Modifies the Association Between Anti-LG3 Antibodies and Delayed Graft Function in Kidney Recipients
por: Mawad, Habib, et al.
Publicado: (2023)

Efficacy of Acute Cellular Rejection Treatment According to Banff Score in Kidney Transplant Recipients: A Systematic Review
por: Lamarche, Caroline, et al.
Publicado: (2016)

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
por: Cabezas, Lara, et al.
Publicado: (2022)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
por: Wijnsma, Kioa Lente, et al.
Publicado: (2019)

Advances in diagnosing and managing antibody-mediated rejection
por: Jordan, Stanley C., et al.
Publicado: (2010)

Updates on antibody-mediated rejection in intestinal transplantation
por: Wu, Guo-Sheng
Publicado: (2016)

Rituximab use in late antibody-mediated rejection
por: Bansal, S. B.
Publicado: (2016)

Antibody-mediated rejection after lung transplantation
por: Bery, Amit I., et al.
Publicado: (2020)

Can eculizumab be discontinued in aHUS?: Case report and review of the literature
por: Sahutoglu, Tuncay, et al.
Publicado: (2016)

Eculizumab as rescue therapy in severe resistant lupus nephritis
por: Pickering, Matthew C., et al.
Publicado: (2015)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019)

Antibody-Mediated Rejection of the Heart in the Setting of Autoimmune Demyelinating Polyneuropathy: A Case Report and Review of the Literature
por: Lindley, Kathryn J., et al.
Publicado: (2012)

Laparoscopic Splenectomy to Salvage Renal Transplants from Severe Acute Antibody-Mediated Rejection
por: Latzko, Michael, et al.
Publicado: (2012)

36-Year-Old Female with Catastrophic Antiphospholipid Syndrome Treated with Eculizumab: A Case Report and Review of Literature
por: Strakhan, Marianna, et al.
Publicado: (2014)

The Proteome of Antibody-Mediated Rejection: From Glomerulitis to Transplant Glomerulopathy
por: Chauveau, Bertrand, et al.
Publicado: (2022)

Eculizumab for pediatric dense deposit disease: A case report and literature review
por: Kasahara, Katsuaki, et al.
Publicado: (2020)

Eculizumab Dosing in Infants
por: Kobrzynski, M., et al.
Publicado: (2018)

Antibody-Mediated Rejection in Kidney Transplantation: A Review
por: Puttarajappa, Chethan, et al.
Publicado: (2012)

Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes
por: Blume, Olivia R., et al.
Publicado: (2012)

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
por: Chih, Sharon, et al.
Publicado: (2012)

Acute antibody-mediated rejection after intestinal transplantation
por: Wu, Guo-Sheng, et al.
Publicado: (2016)

Antibody-mediated rejection: prevention, monitoring and treatment dilemmas
por: Rodriguez-Ramirez, Sonia, et al.
Publicado: (2022)

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
por: Abuazzam, Farah, et al.
Publicado: (2023)

Hyperacute Antibody-mediated Rejection Associated With Red Blood Cell Antibodies
por: Shaw, James, et al.
Publicado: (2019)

Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection
por: Butler, Carrie L., et al.
Publicado: (2017)

Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
por: Umscheid, Jacob H., et al.
Publicado: (2021)

Salvaging of severely ruptured living-related renal allograft secondary to acute antibody mediated rejection
por: Almarastani, Mohamad, et al.
Publicado: (2014)

A severe Mycoplasma pneumoniae pneumonia inducing an acute antibody-mediated pulmonary graft rejection
por: Démir, Sarah, et al.
Publicado: (2017)

Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome
por: McCombe, Jennifer A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tfalvahs0269iavmdgs2q1g8bh